You are here

Clinical Trials: Cord Blood

Condition:   Hypoplastic Left Heart Syndrome
Interventions:   Biological: Autologous (self) mononuclear cells derived from umbilical cord blood;   Procedure: Stage II Surgical repair
Sponsors:   Timothy J. Nelson;   University of Oklahoma;   Children's Hospital of Philadelphia;   Children's Hospital Los Angeles;   Children's Hospital Colorado;   Children's Hospitals and Clinics of Minnesota
Not yet recruiting
Condition:   Psoriasis
Interventions:   Biological: Mesenchymal Stem Cells;   Drug: Oral Methotrexate
Sponsor:   Central South University
Not yet recruiting
Conditions:   Safety Issues;   Effect of Drugs;   Neonatal Death
Interventions:   Drug: 0.9% Sodium-chloride;   Other: Autologous Umbilical Cord Blood Stem Cells Therapy
Sponsor:   Guangdong Women and Children Hospital
Not yet recruiting
Conditions:   AML;   NHL;   Hodgkin Disease;   All
Intervention:   Drug: Hyperbaric oxygen
Sponsor:   University of Rochester
Not yet recruiting
Condition:   Acute Ischemic Stroke
Intervention:   Biological: HPC, Cord Blood
Sponsor:   BHI Therapeutic Sciences
Not yet recruiting
Conditions:   Hematopoietic Stem Cell Transplantation;   Haplo-identical Donor;   Cord Blood;   Hematologic Diseases
Interventions:   Procedure: haplo-SCT;   Procedure: haplo-cord SCT
Sponsor:   The First Affiliated Hospital of Soochow University
Conditions:   Safety Issues;   Effect of Drugs
Interventions:   Other: autologous umbilical cord blood stem cells;   Drug: 0.9% Sodium-chloride
Sponsor:   Guangdong Women and Children Hospital
Not yet recruiting
Condition:   Androgenic Alopecia
Interventions:   Other: conditioned media of umbilical cord blood-derived stem cells;   Other: Placebo
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Conditions:   Acute Myeloid Leukemia;   Acute Lymphocytic Leukemia;   Biphenotypic/Undifferentiated Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplasia;   Relapsed Large Cell Lymphoma;   Mantle Cell Lymphoma;   Hodgkin Lymphoma;   Burkitt Lymphoma;   Relapsed T-Cell Lymphoma;   Lymphoplasmacytic Lymphoma
Interventions:   Drug: Fludarabine (FLU);   Drug: Cyclophosphamide (CY);   Drug: Total Body Irradiation (TBI);   Drug: Tacrolimus (Tac);   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte Colony-Stimulating Factor (G-CSF);   Drug: Busulfan (BU);   Drug: Melphalan;   Drug: MGTA 456 Infusion
Sponsor:   Masonic Cancer Center, University of Minnesota
Not yet recruiting
Condition:   Ulcerative Colitis (UC)
Interventions:   Biological: Adipose-cord mesenchymal stromal cells (A-MSCs);   Other: Conventional drugs
Sponsor:   Liaocheng People's Hospital